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Abstract
Purpose—Estimate quality-adjusted life expectancy (QALE) loss due to smoking and examine 
trends and state differences in smoking-related QALE loss in the U.S.
Methods—Population health-related quality of life (HRQOL) scores were estimated from the 
Behavioral Risk Factor Surveillance System. This study constructed life tables based on U.S. 
mortality files and the mortality linked National Health Interview Survey and calculated QALE for 
smokers, non-smokers, and the total population.
Results—In 2009, an 18-year-old smoker was expected to have 43.5 (SE = 0.2) more years of 
QALE, and a non-smoker of the same age was expected to have 54.6 (SE = 0.2) more years of 
QALE. Therefore, smoking contributed 11.0 (SE = 0.2) years of QALE loss for smokers and 4.1 
years (37%) of this loss resulted from reductions in HRQOL alone. At the population level, 
smoking was associated with 1.9 fewer years of QALE for U.S. adults throughout their lifetime, 
starting at age 18.
Conclusions—This study demonstrates an application of a recently developed QALE estimation 
methodology. The analyses show good precision and relatively small bias in estimating QALE—
especially at the individual level. Although smokers may live longer today than before, they still 
have a high disease burden due to morbidities associated with poor HRQOL.
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Introduction
Smoking remains the leading cause of disease and death in the United States and is a risk 
factor for multiple chronic diseases including cancer (lung and other sites), coronary heart 
disease, cardiovascular diseases (such as stroke), and respiratory problems [1, 2]. Annually 
in the United States, smoking causes 443,000 premature deaths among adults, contributes to 
approximately 5.1 million years of potential of life lost (YPLL), and costs more than $193 
billion in lost productivity and healthcare expenditures [3].
While steep declines in the prevalence of smoking among adults have been observed since 
1965, from 2004 to 2009, this decline in prevalence has stalled [4]. From 2003 to 2009, the 
rate of decline in youth smoking has also slowed so that 1 in 5 youth and 1 in 5 adults now 
currently smoke cigarettes. Given these current trends in smoking and its status as the 
leading cause of disease and death in the United States, conducting comparative analyses of 
burden of disease associated with smoking is important to assist in cost-effectiveness 
analyses of alternative health policies, intervention programs, or treatments to make further 
progress in reducing smoking prevalence [5, 6].
When examining the total health impact from a risk factor or a disease, such measures of 
burden necessarily include non-fatal morbidity such as disease, disability, or poor health–
related quality of life (HRQOL), as well as life lost to premature death [5]. Thus, single 
indicators, such as the quality-adjusted life expectancy (QALE), are particularly useful for 
quantifying burden associated with behavioral risk factors, determinants of health, diseases, 
and injuries [7, 8]. Since HRQOL scores differ substantially across the life span, calculating 
life expectancy adjusted for HRQOL would provide a more complete assessment of overall 
health throughout the entire life span [6–8].
Kaplan et al. [9] estimated QALE loss due to smoking using the 1986–1994 National Health 
Interview Survey (NHIS) linked mortality file. Scores for the Quality of Well-being Scale 
(QWB) for participants in the NHIS were estimated based on responses to a set of measures 
highly correlated with the QWB. They then estimated mortality-adjusted HRQOL using 
polynomial regressions [9, 10]. The QALE loss was approximated by summarizing the 
mortality-adjusted HRQOL between ages 18 and 70. However, as the authors pointed out, 
this study underestimated QALE loss because it excluded losses for individuals older than 
70 years. An additional weakness of the study was that state-level estimates and long-term 
trends could not be examined. Stewart et al. [11] used the Euro-Qol group’s EQ-5D 
questions in the 2003 Medical Expenditure Panel Survey (MEPS), to obtain age-specific 
HRQOL scores and extrapolated future HRQOL scores as well as the prevalence of smoking 
to predict the long-term trends of QALE loss (from 2005 to 2020) due to smoking in the 
United States. Since this study relied on a single year of cross-sectional HRQOL data to 
predict HRQOL scores for future years, the projected estimates were less precise for years 
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beyond 2003. Neither of these two studies was able to estimate standard errors or confidence 
intervals.
A recent study proposed a method to calculate U.S. State-level QALE by constructing life 
tables for each state and then applying population HRQOL scores, estimated from the 
ongoing state-based Behavioral Risk Factor Surveillance System (BRFSS), to these life 
tables [8]. This paper described the method to calculate QALEs and their standard errors and 
examined both trends (1993–2009) and between-state differences of QALE. The study 
demonstrated that the state estimates were reliable and that the national estimates were 
weakly biased.
The aim of the present study is to describe and apply a novel method to calculate QALE loss 
due to a specific risk factor (or a disease), smoking, using currently available data sets. 
Specifically, this study presents an application of a recently developed QALE methodology 
to examine recent U.S. trends and state-level variations in QALE loss due to smoking. 
Moreover, the study compares smoking-related QALE loss due to reductions in HRQOL 
relative to QALE loss due to shortened life expectancy.
Methods
The 1993–2009 BRFSS was used for estimating smoking status and HRQOL among 
respondents. The BRFSS is a state-based survey of non-institutionalized civilian adult 
residents from each of the fifty states and the District of Columbia [12, 13]. The BRFSS 
uses multistage, stratified, probabilistic sampling methods to draw representative samples of 
U.S. adults [13]. In addition to an unequal probability sampling weight, the BRFSS survey 
weight includes a post-stratification weight to correct for sampling bias due to non-response 
and non-coverage, which we have included in all analyses [13].
The BRFSS assesses current smoking status by asking two questions: (1) Have you smoked 
at least 100 cigarettes in your entire life? and (2) Do you now smoke every day, someday or 
not at all? Respondents who reported both ever having smoked 100 cigarettes and now 
smoking every day or some days were defined as current smokers [2–4]. Non-smokers 
included never smokers and former smokers.
The QALE uses preference-based measurements of HRQOL to capture respondents’ 
perceived health for different health states using a summary score (also called a utility 
value), which is set 0 for death and 1 for perfect health [7, 14]. Thus, 1 year of life lived at a 
utility value of 0.8 is equal to 0.8 quality-adjusted life years [5, 15]. The BRFSS asked 
respondents to rank their general health from 1 (excellent) to 5 (poor) and to report numbers 
of their physically unhealthy days, mentally unhealthy days, and days with activity 
limitation during the past 30 days [16]. Because these measures are not preference based, 
they cannot be used to calculate QALE directly [16–18]. Thus, the present study employs a 
previously constructed mapping algorithm based on BRFSS respondents’ age and answers to 
these four questions to estimate values for a frequently used preference-based HRQOL 
measurement, the EQ-5D index [19–21]. This algorithm provides valid estimates of EQ-5D 
scores of the U.S. population from the BRFSS [8, 20], and the bias of estimated QALE from 
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these scores has been estimated to be less than 1% of that using the actual observed EQ-5D 
[8].
Premature deaths attributed to smoking
The U.S. Centers for Disease Control and Prevention (CDC) compiled public use data sets 
that were available through 2006 that include death summary statistics (accessible at http://
wonder.cdc.gov). For the years 2007–2009, these death data are not available. The U.S. 
Census Bureau provides annual population estimates (available till 2009, accessible at 
www.census.gov/popest/states/asrh/). Both sets of data are available by state, age, gender, 
and other basic demographics. However, since the national and state death rates were 
relatively stable across the time period we analyzed, we estimated these death rates for the 
three missing years, 2007 through 2009, using a time-series autoregressive moving average 
model (ARMA) from the 1993–2006 death rates [22].
The age-specific death rate (m) was obtained by dividing the number of deaths (d) by the 
population size (N). Because the number of deaths and the population size by smoking status 
were not available, death rates for current smokers (m1) and non-smokers (m0) were 
estimated using the hazard ratio (h) of dying and smoking prevalence (p) by
respectively. The hazard ratio of dying for smokers to non-smokers was estimated from the 
National Health Interview Survey (NHIS) Linked Mortality Files (available at http://
www.cdc.gov/nchs/data_access/data_linkage/mortality/nhis_linkage.htm), using the Cox 
proportional hazards model. The proportion of population who smoked was estimated from 
the BRFSS.
QALE
Formulas to calculate QALE and their standard errors were provided by Jia, et al. [8], and 
details are in the “Appendix”. Let Ai be the number of persons in a hypothetical population 
surviving to age i. Let Di be the total life years for the age interval i and qi =1 − e−nimi be the 
probability of dying in an ni-year interval and assume that those who died during the interval 
lived an average ni/2 years for ages x < 85, that is, Di = Ai(1 − niqi/2). For the last age 
interval (aged 85 years and older), we assume a constant death rate (m85), so that the 
survival time follows an exponential distribution and that D85 = A85/m85 [8, 15]. Suppose yi 
is the mean HRQOL score, QALE for those at age x is
The individual QALE loss due to smoking is defined as the difference in QALE between 
non-smokers and smokers. Figure 1a illustrates the QALE from age 18–24 through 85+, for 
Jia et al. Page 4













smokers, non-smokers, and total population. The individual QALE loss due to smoking is 
the difference between the non-smokers’ curve and the smokers’ curve. It quantifies the risk 
or burden of smoking at the individual level for a person who smoked (Fig. 1b). At the 
population level, the population QALE is defined as the difference in QALE between non-
smokers and the total population. This is similar to the “population attributable risk” in 
epidemiology, and we will refer to this as population QALE loss.
Two factors contribute to smoking-related QALE loss: mortality and morbidity. The QALE 
loss that can be attributed to mortality only (i.e., shortened life expectancy) was calculated 
by assuming that the HRQOL scores were the same for both smokers and non-smokers, 
while the only difference between them was their mortality rates. Similarly, the QALE loss 
that can be attributed to morbidity only (i.e., reductions in HRQOL) was calculated by 
assuming that the mortality rates were the same between smokers and non-smokers and that 
the only difference between them was their HRQOL scores.
Results
In 2009, an 18-year-old current smoker was predicted to live 53.6 more years, while a non-
smoker (never or former smoker) of the same age was predicted to live 62.5 more years. 
This 9.0-year (SE = 0.3) difference in life expectancy between smokers and non-smokers is 
the loss in life expectancy due to smoking (estimates calculated but not shown). After 
adjustment for HRQOL scores, the QALE at 18 years for smokers, non-smokers, and the 
entire U.S. population were 43.5, 54.6, and 52.6 years, respectively (Fig. 1a). Therefore, 
smoking contributed to an average loss of 11.0 years (=54.6 – 43.5, SE = 0.2) in QALE 
throughout the lifetime of a smoker starting at 18 years. At the population level, smoking 
was expected to reduce the QALE 1.9 years over a lifetime (=54.6 – 52.6, SE = 0.14) for the 
U.S. population starting at 18 years. Both the individual and the population QALE loss due 
to smoking diminished for older age intervals (Fig. 1b). At 85 years, the QALE loss due to 
smoking was 3.3 years (SE = 0.05) and the population QALE loss was only 0.2 years (SE = 
0.02). The steep decline in QALE loss between the ages of 18–24 and age 85+ years 
indicates that smoking affects smokers’ health at younger ages as well as at older ages.
Figure 2a presents the trend in QALE loss due to smoking for those aged 18 years from 
1993 to 2009. The following three curves occur in this figure: total loss, loss attributed to 
mortality, and loss attributed to morbidity. In 1993, for individual risk estimates, the QALE 
for smokers was approximately 9.1 years (SE = 0.1) less than non-smokers. This QALE loss 
increased consistently in subsequent years so that, by 2009, it had increased to 11.0 years, a 
21.9% increase.
When we compared the estimates of the impact of smoking on QALE loss due to morbidity 
and on QALE loss due to mortality, a greater proportion of the QALE loss was due to 
mortality. In 2009, 7.3 years or 66.2% of the total 11.0 years of loss in QALE was due to 
mortality and only 4.1 years (37.4%) due to morbidity. The 0.3 years (=11.0 – 7.3 – 4.1) of 
overlap was probably due to the correlation between mortality rates and HRQOL scores. 
The QALE loss due to morbidity had increased from 2.0 years in 1993 to 4.1 years in 2009 
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(a 105% increase), while the QALE loss due to mortality remained relatively constant 
(around 7.3 years).
For population-level burdens (Fig. 2b), smoking contributed about 2.0 years of population 
QALE loss for an 18-year-old, an amount stable across the 17-year time period. However, 
population life expectancy loss due to smoking without adjustment for HRQOL during this 
time period had declined consistently from 1.9 years in 1993 to 1.4 years in 2009, a 23.8% 
decline (data not shown). When we examined the loss attributed to mortality and morbidity 
separately, of the 1.9-year loss in population QALE in 2009, 1.2 years (60.2%) were due to 
mortality and 0.8 years (39.7%) due to morbidity. The population QALE loss due to 
smoking attributed to mortality had declined from 1.5 years in 1993 to 1.2 years in 2009, a 
24.5% decline. Meanwhile, the population QALE loss due to morbidity had increased from 
0.48 years to 0.77 years (a 61.9% increase) during the same time period.
States varied in the amount of QALE lost to smoking (Table 1). In 2006, the most recent 
year when state death data are available (state-level data for other years are available upon 
request) states with the least loss of QALE due to smoking in the population were Utah (1.1 
years), Connecticut (1.4), California (1.5), Minnesota (1.5), and Colorado (1.6); states with 
the greatest loss of QALE due to smoking in the population were Kentucky (2.9), West 
Virginia (2.9), Oklahoma (2.8), Arkansas (2.7), and Mississippi (2.2). QALE loss due to 
smoking and life expectancy were both strongly associated with smoking prevalence rates (r 
= 0.88 and 0.81 for QALE and life expectancy, respectively).
Finally, we examined the sensitivity of using a mapping algorithm to obtain HRQOL scores 
from the BRFSS in the calculation of QALE. For the 2000–2003 MEPS cohorts, a nationally 
representative sample of 72,249 adults was asked the EQ-5D questions. We compared the 
QALE loss due to smoking in 2000–2003 using the estimated EQ-5D index from the 
HRQOL scores from the BRFSS and the observed EQ-5D from the MEPS. The mean 
differences between estimates using the BRFSS mapping algorithm, and the actual EQ-5D 
scores from the MEPS were approximately −0.25-year loss for smokers and −0.15-year loss 
for the entire population, resulting in underestimations of the QALE loss for smokers by 
2.5% and of the population QALE loss by 7.0% (Table 2).
Discussion
The present study demonstrates use of a method to characterize trends in the total health 
burden of a disease or a risk factor (in this case, smoking), using a single index that 
incorporates both morbidity and mortality outcomes. Given the voluminous research over 
the past 50 years showing that cigarette smoking significantly affects both morbidity (i.e., 
chronic diseases and lower HRQOL scores) and mortality (i.e., premature death) throughout 
different stages of life [1–4], the QALE provides a novel approach to understanding the 
overall lifetime impact of smoking using a single value.
Unlike previous studies [9, 11], this study defined and calculated burden of disease both as 
an individual-level burden (among smokers) and a population-level burden (to the 
population as whole) separately. For the individual-level burden, the QALE loss due to 
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smoking quantifies the degree to which risk can be prevented or reduced for current smokers 
if they were not to smoke (i.e., to quit or never to have started). This measure may provide a 
more useful means than the population-level burden to evaluate treatment for diseases 
caused by smoking. From our study, we drew two conclusions. First, because two-thirds of 
the 11.0-year QALE loss related to smoking in 2009 could be attributed to shortened life 
expectancy or mortality, the main burden of smoking is still premature death. Second, 
because the life expectancy of smokers had increased from 51.8 to 60.8 years between 1993 
and 2009 while during this period, the smoking-related QALE loss attributed to mortality 
remained nearly unchanged and the smoking-related QALE loss attributed to mortality had 
increased more than twofold, from 2.0 to 4.1 years, smokers had had declining HRQOL, 
which likely contributed to higher smoking-related burden.
The population QALE loss due to smoking, the burden to the entire population, measures 
the maximum number of QALE for the entire population that would be gained if all smokers 
did not smoke (quit or never to have started). This application may particularly be useful for 
evaluating health policies or intervention programs on smoking prevention. Our analysis 
showed that smoking attributed approximately 2.0 years of QALE loss for the entire U.S. 
population in their lifetime starting at age 18 years in recent years. Our proposed method can 
also be used to calculate the QALE for a population with any a given value of smoking 
prevalence. For example, achieving one of the Health People 2020 goals of lowering 
smoking prevalence to 12% for the overall United States [6] would increase QALE 0.61 
years for the entire U.S. population.
Stewart et al. [11] previously calculated population QALE lost using 2003 MEPS data and 
found that smoking contributed to 2.2 years of population QALE lost, which was greater 
than our estimation of 2.0 years of population QALE lost in 2003. However, most of the 0.2-
year difference appears due to the different data used in these two studies to obtain smoking 
prevalence: Stewart used the MEPS, and we used the BRFSS. We recalculated the 
population QALE loss using the smoking prevalence estimated from the MEPS, and the 
difference between these two studies decreased to 0.024 years. Therefore, using the BRFSS 
to obtain HRQOL scores underestimated the population QALE loss by 1.2%, after adjusting 
for the discrepancy between the BRFSS and the MEPS.
Although smoking-related QALE loss to the population was almost unchanged between 
1993 and 2009, losses due to mortality had declined nearly 25% while the losses due to 
morbidity had increased more than 60%. This finding is consistent with CDC studies that 
show that both smoking attributed mortality and YPLL due to smoking among U.S. adults 
have decreased in recent years [2, 3], probably because life expectancy had increased and 
because smoking prevalence had declined in nearly all population subgroups [8, 23, 24]. 
Meanwhile, HRQOL in U.S. adults had also declined thus increasing QALE loss due to 
morbidity [25]. If the adult smoking prevalence remains constant, then the health burden of 
smoking to U.S. population would remain stable because the observed increasing effects of 
smoking on morbidity would offset the decreases related to mortality [4].
Ideally, QALE should be estimated from a longitudinal study in which HRQOL and 
mortality would be estimated simultaneously. But in practice, such longitudinal data are 
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usually not available or too sparse to provide reliable estimates. Many investigators have 
estimated the mean HRQOL and the survival function separately from different data sets [8, 
10]. The primary weakness associated with this approach is its inability to provide estimates 
of precision. Previous analyses have not calculated standard errors (or confidence intervals) 
for their QALE estimates [9, 10]. In this study, we describe a method to calculate standard 
errors of the estimates by assuming independence of the HRQOL and mortality rates. This 
independence assumption was tested in an earlier paper where the correlations between 
HRQOL scores and mortality rates had a very small impact (<1% relative difference) on the 
variance estimation of QALE [8].
The main limitation is the potential bias in the estimates. The present study relied on the 
unhealthy days questions in the BRFSS to estimate preference-based HRQOL scores. The 
only other large and population data that included preference-based HRQOL questions were 
available from MEPS [18]. Therefore, estimates of smoking-related QALE loss would likely 
be underestimated [8, 20, 26, 27] in our study. Our estimates of smoking-related QALE loss 
in the population may also be underestimated because they do not account for possible 
mortality of other persons due to second-hand smoke or fire injury. In fact, our sensitivity 
analysis comparing BRFSS and MEPS shows that these underestimations were about 2.5% 
for QALE loss to smoking and 7% for population QALE loss. We consider such biases 
acceptable given the lack of other preference-based HRQOL data for such estimation. Also, 
part of the discrepancy between the MEPS and the BRFSS was due to sampling differences 
between these surveys. The actual bias can be as small as 1.2% for population QALE loss. 
Second, the number of BRFSS respondents and the number of deaths might be too small to 
provide reliable estimates for all states. Because some questions were not asked in all states 
every year, we had to rely on moving averages to obtain estimates for these years and states. 
Nonetheless, standard errors of almost all (93.5%) of these state-level estimates were less 
than 0.5 year, and all of the relative standard errors were<30%.
Smoking status was based on self-report and was not validated by biochemical tests. 
However, using the levels of serum cotinine (a breakdown product of nicotine), similar 
prevalence estimates were observed as those obtained from self-reports [28]. Finally, for the 
more recent years of BRFSS data collection, adults without telephone service or with 
wireless-only service who more often currently smoke than adults with landline telephones 
were excluded so that the overall adult smoking prevalence estimates in this study were 
likely underestimated [29].
In summary, this study presents a method to estimate lifetime burdens due to smoking by 
calculating the QALE, a single measure that encompasses smoking-related morbidity and 
mortality to smokers only and for the entire population. One of the primary advantages of 
this method is its ability to use currently available data to estimate trends in the burden of 
smoking for U.S. states as far back as 1993. While the method is novel, it has the potential 
to provide estimates of geographic variations between states as well as some large substate 
areas. Furthermore, demographic subgroups can be examined such as by sex and race (data 
stratified by sex are available upon request). The method developed here may also be 
applied to randomized controlled trials to compare outcomes between treatment and control 
groups for the cost-effective analysis of alternative treatments [5, 14]. The potential utility of 
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the QALE outlined in this study provides a means to obtain burden of smoking estimates 
essential for setting targets to reduce health risks from cigarette smoking, eliminating health 
disparities, and assisting policy makers with decision making [6].
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Appendix
The QALE at age x is calculated by summarizing QALYs throughout remaining expected 
life starting at age x over the percent of population surviving to age x [7, 8]:
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where y(t) are HRQOL scores at age t and S(t) is the survival function. Formulas to calculate 
QALE and their standard errors were provided by Jia et al. [8]. QALE for those at age x is:
The variance of this QALE estimate is:
where  for age less than 85 and .
QALE loss was the difference in QALE between two groups: . Here,  is 
QALE for non-smokers and  is QALE for smokers (for individual QALE loss) or for total 
population (for population QALE loss). The variance of QALE loss is equal to 
. The covariance term is approximated by
where  and  for i < 85.
Since the number of deaths is estimated from the proportion at risk and the hazard ratio, 
additional variation from the unreliability of using the estimated proportion (var(p)) and 
hazard ratio (var(h)) should be included in the variance estimation for q, the probability of 
dying:
The values of var(p) and var(h) are derived from methods of moments estimation (either 
using designed based on direct estimates or using model-based estimates). For the years 
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2007–2009, the death data were estimated from a time-series autoregressive moving average 
model (ARMA) from the 1993–2006 death rates [8, 22]. The death rate at year t, mt, is 
specified as ARMA(1,1) or mt − μ = ρ(mt−1 − μ) + et − βet−1. The predicted death rates for 
these 3 years therefore should include additional uncertainty in their estimates, and the 
variance, var(m), from the ARMA model estimates was used to account for this.
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QALE by age group and smoking status (a), and the amount of QALE loss (b) due to 
smoking among smokers (individual QALE loss) and in the entire population (population 
QALE loss), 2006
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Trend of QALE Loss (a) and population QALE loss (b) due to smoking at 18 years: total 
loss, loss to shortened life expectancy only, and loss to reductions in HRQOL only, 1993–
2009
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